Literature DB >> 8548137

'Just grin and bear it and hope that it will go away': coping with urinary symptoms from pelvic radiotherapy.

S Faithfull.   

Abstract

Fifty per cent of patients with cancer are treated with radiotherapy during the course of their disease. Although side-effects have been described in studies, these are often not representative of the impact that these symptoms have on the individual. This article explores one area of radiotherapy management, that of pelvic radiotherapy in men, and describes how symptoms that patients experience during and following treatment can be a debilitating outcome of cancer therapy. At present, there is limited knowledge on how best to prevent symptoms from occurring, who is most at risk and how to manage these symptoms. Technology has advanced with accelerated regimes, conformal planning and new radiotherapy treatments. Yet still we are no further forward in dealing with toxicity from treatment. The focus of research has been on developing new cures and only now are questions being raised about the quality of life of patients having radiotherapy treatment.

Entities:  

Mesh:

Year:  1995        PMID: 8548137     DOI: 10.1111/j.1365-2354.1995.tb00087.x

Source DB:  PubMed          Journal:  Eur J Cancer Care (Engl)        ISSN: 0961-5423            Impact factor:   2.520


  7 in total

1.  Gastrointestinal complications of pelvic radiotherapy: are they of any importance?

Authors:  J Andreyev
Journal:  Gut       Date:  2005-08       Impact factor: 23.059

2.  Gastrointestinal symptoms after pelvic radiotherapy: a national survey of gastroenterologists.

Authors:  C C Henson; S E Davidson; A Lalji; R P Symonds; R Swindell; H J N Andreyev
Journal:  Support Care Cancer       Date:  2011-11-13       Impact factor: 3.603

3.  Patient-reported symptoms and quality of life integrated into clinical cancer care.

Authors:  Donna L Berry
Journal:  Semin Oncol Nurs       Date:  2011-08       Impact factor: 2.315

4.  Conceptualizing global health-related quality of life in bladder cancer.

Authors:  Nathan Perlis; Murray Krahn; Shabbir Alibhai; Antonio Finelli; Paul Ritvo; Karen E Bremner; Girish Kulkarni
Journal:  Qual Life Res       Date:  2014-04-13       Impact factor: 4.147

5.  Practice guidance on the management of acute and chronic gastrointestinal problems arising as a result of treatment for cancer.

Authors:  H Jervoise N Andreyev; Susan E Davidson; Catherine Gillespie; William H Allum; Edwin Swarbrick
Journal:  Gut       Date:  2011-11-04       Impact factor: 23.059

6.  A modified Inflammatory Bowel Disease questionnaire and the Vaizey Incontinence questionnaire are simple ways to identify patients with significant gastrointestinal symptoms after pelvic radiotherapy.

Authors:  F A Olopade; A Norman; P Blake; D P Dearnaley; K J Harrington; V Khoo; D Tait; C Hackett; H J N Andreyev
Journal:  Br J Cancer       Date:  2005-05-09       Impact factor: 7.640

7.  Evaluation of nurse-led follow up for patients undergoing pelvic radiotherapy.

Authors:  S Faithfull; J Corner; L Meyer; R Huddart; D Dearnaley
Journal:  Br J Cancer       Date:  2001-12-14       Impact factor: 7.640

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.